{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:02:53Z","timestamp":1779688973998,"version":"3.53.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,24]]},"DOI":"10.7759\/cureus.109574","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:12:32Z","timestamp":1779685952000},"source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Real-World Multicenter Study of the Efficacy and Safety of Desidustat in Chronic Kidney Disease-Related Anemia"],"prefix":"10.7759","author":[{"given":"Sanjeev","family":"Gulati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Pahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Rungta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V K","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Bendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20222135","article-title":"Prevalence of anemia among chronic kidney disease patients in India: a single-centre study","volume":"11","author":"Zaawari A","year":"2022","unstructured":"Zaawari A, Tejaswini KL, Davina GD, Singanaveni A. Prevalence of anemia among chronic kidney disease patients in India: a single-centre study. Int J Basic Clin Pharmacol. 2022, 11:404-9. 10.18203\/2319-2003.ijbcp20222135","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12367","article-title":"Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: evidence from a cross-sectional study","volume":"12","author":"Hussain S","year":"2019","unstructured":"Hussain S, Habib A, Najmi AK. Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: evidence from a cross-sectional study. J Evid Based Med. 2019, 12:243-52. 10.1111\/jebm.12367","journal-title":"J Evid Based Med"},{"key":"ref3","article-title":"The effects in correction of anaemia in chronic kidney disease with erythropoietin therapy--preference to cardiovascular, neurologic and general well-being of patients from a tertiary care centre","volume":"110","author":"Mukhopadhyay P","year":"2012","unstructured":"Mukhopadhyay P, Sinha U, Banerjee J, Choudhury AR, Philips CA. The effects in correction of anaemia in chronic kidney disease with erythropoietin therapy--preference to cardiovascular, neurologic and general well-being of patients from a tertiary care centre. J Indian Med Assoc. 2012, 110:885-8.","journal-title":"J Indian Med Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-022-02920-6","article-title":"Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients","volume":"23","author":"Pan W","year":"2022","unstructured":"Pan W, Han Y, Hu H, He Y. Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients. BMC Nephrol. 2022, 23:295. 10.1186\/s12882-022-02920-6","journal-title":"BMC Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2013.093","article-title":"Pathophysiology of anemia in chronic kidney diseases: a review","volume":"159","author":"Zadrazil J","year":"2015","unstructured":"Zadrazil J, Horak P. Pathophysiology of anemia in chronic kidney diseases: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015, 159:197-202. 10.5507\/bp.2013.093","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin--a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky J","year":"2009","unstructured":"Zaritsky J, Young B, Wang HJ, et al.. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4:1051-6. 10.2215\/CJN.05931108","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.67961\/gin-2046","article-title":"The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease","volume":"38","author":"Angelini A","year":"2021","unstructured":"Angelini A, Cappuccilli ML, Magnoni G, et al.. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol. 2021, 38:2021-vol4. 10.67961\/gin-2046","journal-title":"G Ital Nefrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.05.002","article-title":"Novel oral iron therapies for iron deficiency anemia in chronic kidney disease","volume":"26","author":"Pergola PE","year":"2019","unstructured":"Pergola PE, Fishbane S, Ganz T. Novel oral iron therapies for iron deficiency anemia in chronic kidney disease. Adv Chronic Kidney Dis. 2019, 26:272-91. 10.1053\/j.ackd.2019.05.002","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40610-019-0110-9","article-title":"Regulation of fibroblast growth factor 23 by iron, EPO, and HIF","volume":"5","author":"Wheeler JA","year":"2019","unstructured":"Wheeler JA, Clinkenbeard EL. Regulation of fibroblast growth factor 23 by iron, EPO, and HIF. Curr Mol Biol Rep. 2019, 5:8-17. 10.1007\/s40610-019-0110-9","journal-title":"Curr Mol Biol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae075","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice Board of the European Renal Association","volume":"39","author":"Stoumpos S","year":"2024","unstructured":"Stoumpos S, Crowe K, Sarafidis P, et al.. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice Board of the European Renal Association. Nephrol Dial Transplant. 2024, 39:1710-30. 10.1093\/ndt\/gfae075","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000523949","article-title":"Desidustat in anemia due to dialysis-dependent chronic kidney disease: a phase 3 study (DREAM-D)","volume":"53","author":"Gang S","year":"2022","unstructured":"Gang S, Khetan P, Varade D, et al.. Desidustat in anemia due to dialysis-dependent chronic kidney disease: a phase 3 study (DREAM-D). Am J Nephrol. 2022, 53:343-51. 10.1159\/000523949","journal-title":"Am J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000523961","article-title":"Desidustat in anemia due to non-dialysis-dependent chronic kidney disease: a phase 3 study (DREAM-ND)","volume":"53","author":"Agrawal D","year":"2022","unstructured":"Agrawal D, Varade D, Shah H, et al.. Desidustat in anemia due to non-dialysis-dependent chronic kidney disease: a phase 3 study (DREAM-ND). Am J Nephrol. 2022, 53:352-60. 10.1159\/000523961","journal-title":"Am J Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.13249","article-title":"A real-world experience of desidustat in maintenance hemodialysis patients-a 1-year retrospective database analysis from a single center: desidustat-a real world experience in hemodialysis patients from a single center","volume":"38","author":"Jeloka T","year":"2025","unstructured":"Jeloka T, Sanwaria P, Khiste S. A real-world experience of desidustat in maintenance hemodialysis patients-a 1-year retrospective database analysis from a single center: desidustat-a real world experience in hemodialysis patients from a single center. Semin Dial. 2025, 38:139-45. 10.1111\/sdi.13249","journal-title":"Semin Dial"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.05.028","article-title":"Treatment of anemia in kidney disease: beyond erythropoietin","volume":"6","author":"Wish JB","year":"2021","unstructured":"Wish JB. Treatment of anemia in kidney disease: beyond erythropoietin. Kidney Int Rep. 2021, 6:2540-53. 10.1016\/j.ekir.2021.05.028","journal-title":"Kidney Int Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473843-a-retrospective-real-world-multicenter-study-of-the-efficacy-and-safety-of-desidustat-in-chronic-kidney-disease-related-anemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:12:33Z","timestamp":1779685953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473843-a-retrospective-real-world-multicenter-study-of-the-efficacy-and-safety-of-desidustat-in-chronic-kidney-disease-related-anemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.109574","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,24]]}}}